Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin
Sponsor: Tanta University
Summary
This study aims to assess the cardioprotective effect of melatonin and vitamin D in breast cancer patients who receive doxorubicin.
Official title: Clinical Study Evaluating Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2026-04-30
Completion Date
2026-08-30
Last Updated
2026-01-16
Healthy Volunteers
No
Interventions
Group 1 (Doxorubicin group)
30 patients will receive a traditional chemotherapeutic agent (Doxorubicin group) for 12 weeks.
Group 2: Vitamin D group
patients with Vitamin D supplementation (1000 iu/day) plus traditional therapy for 12 weeks
Group 3: melatonin group
patients with 10 mg of melatonin orally, once daily plus traditional therapy for 12 weeks
Locations (1)
Tanta University
Tanta, Egypt